Page:Danco Laboratories, LLC v. Alliance for Hippocratic Medicine (U.S. April 21, 2023).pdf/4

This page has been validated.
4
DANCO LABORATORIES, LLC v. ALLIANCE FOR HIPPOCRATIC MEDICINE

Alito, J., dissenting

regulations then in force prohibited, and here, the Government has not dispelled legitimate doubts that it would even obey an unfavorable order in these cases, much less that it would choose to take enforcement actions to which it has strong objections.

For these reasons, I would deny the stay applications. Contrary to the impression that may be held by many, that disposition would not express any view on the merits of the question whether the FDA acted lawfully in any of its actions regarding mifepristone. Rather, it would simply refuse to take a step that has not been shown as necessary to avoid the threat of any real harm during the presumably short period at issue.